| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 553 |
| 1 | DEXAMETHASONE | 513 |
| 2 | DEXAMETHASONE 1.5 MG | 513 |
| 3 | ASPIRIN | 400 |
| 4 | ASPIRIN 325 MG | 392 |
| 5 | ASPIRIN 81 MG | 392 |
| 6 | PREDNISONE | 375 |
| 7 | CYCLOPHOSPHAMIDE | 334 |
| 8 | CYCLOPHOSPHAMIDE FOR INJECTION | 334 |
| 9 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 334 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CHLOROQUINE PHOSPHATE | 19 | 0.0289 |
| 1 | BELINOSTAT | 10 | 0.0279 |
| 2 | ANDEXANET ALFA | 15 | 0.0212 |
| 3 | POTASSIUM PHOSPHATE, MONOBASIC AND SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS | 3 | 0.0164 |
| 4 | GALLIUM GA-68 GOZETOTIDE | 3 | 0.0147 |
| 5 | VORINOSTAT | 31 | 0.0143 |
| 6 | ETHIODIZED OIL | 18 | 0.0139 |
| 7 | SACCHAROMYCES CEREVISIAE | 12 | 0.0131 |
| 8 | PHENAZOPYRIDINE HYDROCHLORIDE | 4 | 0.0121 |
| 9 | SODIUM ACETATE | 3 | 0.0105 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 1097 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 841 |
| 2 | Platinum-based Drug [EPC] | 671 |
| 3 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 595 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 504 |
| 5 | Microtubule Inhibitor [EPC] | 428 |
| 6 | Alkylating Drug [EPC] | 427 |
| 7 | Platelet Aggregation Inhibitor [EPC] | 420 |
| 8 | Factor Xa Inhibitor [EPC] | 406 |
| 9 | Thalidomide Analog [EPC] | 330 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Histone Deacetylase Inhibitor [EPC] | 43 | 0.0111 |
| 1 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 4 | 0.0103 |
| 2 | Vasoconstrictor [EPC] | 2 | 0.0067 |
| 3 | Non-Standardized Fungal Allergenic Extract [EPC] | 12 | 0.0056 |
| 4 | Anti-coagulant [EPC] | 17 | 0.0046 |
| 5 | Thrombopoietin Receptor Agonist [EPC] | 68 | 0.0045 |
| 6 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 8 | 0.0035 |
| 7 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 5 | 0.0033 |
| 8 | Antihypoglycemic Agent [EPC] | 14 | 0.0033 |
| 9 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 595 | 0.0032 |